Vaccines, Blood & Biologics
?
-
Blood Research
-
Cellular Hematology
Studies on Safety and Efficacy of Platelets and Other Transfused Blood Products
Jaroslav Vostal, MDBlood Safety: Developing Methods to Reduce Infectious Agents in Blood and Related Products and Identifying Biomarkers of Stored Blood Cells
C.D. Atreya, PhDInvestigation of Potential Toxic Effects of Engineered Nanoparticles and Biologic Microparticles in Blood and Their Biomarker Applications.
Jan Simak, PhD
-
-
Plasma Derivatives
Safety and Efficacy of Immune Globulins and Alpha-1 Proteinase Inhibitors
Dorothy Scott, MDStudies on the Safety and Efficacy of Plasma-derived Products and Their Recombinant Analogs
Basil Golding, MDEvaluation and Characterization of Neutralizing Antibodies against Viruses Relevant to Blood-derived Products
Pei Zhang, PhD
-
-
Hemostasis
Toward More Effective Treatment of Blood Clotting Disorders: Pharmacogenomic Studies of ADAMTS13 and Related Proteins
Chava Kimchi-Sarfaty, PhDStudies of Clearance from the Circulation of the Blood Clotting Factor VIII, Aimed at Improving the Safety and Efficacy of FVIII Products
Andrey Sarafanov, PhDImmunogenicity of Protein-based Therapeutics
Zuben E. Sauna, PhD
-
-
Biochemistry & Vascular Biology
Evaluating the Safety and Efficacy of Hemoglobin-based Blood Substitutes
Abdu I. Alayash, PhDRed Blood Cell Toxicokinetics and Proteomics
Paul W. Buehler, PhDVascular Responses and Biological Product Safety and Efficacy
Felice D'Agnillo, PhD
-
-
Molecular Virology
Improving Safety of the Blood Supply from Transmission of HIV/AIDS and Other Emerging Blood Borne Viral and Biodefense Agents by Developing Sensitive Diagnostic Tools and Investigating Disease Pathogenesis
Indira Hewlett, PhDStudies on a Potential Vaccine for the Treatment of HIV Infection and Sensitive Immunoassays to Simultaneously Detect Multiple Infections and Monitor Post-vaccination Safety
Subhash Dhawan, PhDHIV Infections and the Safety of the Blood Supply
Andrew I. Dayton, MD, PhD
-
-
Emerging Pathogens
Keeping Blood and Blood Products Safe by Developing Tests for Malaria and Other Parasites and Helping to Develop Malaria Vaccine
Sanjai Kumar, PhDStudies to Evaluate Blood Safety: Risk of Transmission of Parasites such as Trypanosoma cruzi through Blood Transfusion
Alain Debrabant, PhDPathogenesis and Diagnosis of Hepatitis A Virus and Other Biodefense Agents
Gerardo Kaplan, PhDImproving the Safety of Blood and Blood Related Products by Reducing the Risk of Transfusion-Transmission of Leishmania Parasites
Hira Nakhasi, PhDReducing Threats to the Blood Supply from West Nile Virus, Dengue Virus, and Chikungunya Virus Through Development of Detection Tools and Studies of Genetic Evolution and Pathogenesis
Maria Rios, PhDDevelopment of in vitro and in vivo Systems for the Evaluation of Products for the Prevention and Detection of Hepatitis B, C and Dengue Viruses in the Blood Supply
Deborah R. Taylor, PhD
-
-
Bacterial and Transmissible Spongiform Encephalopathy Agents
Medical Product Purity: Maintaining Biologics and Other FDA-regulated Products Free of the Infectious Agents of Transmissible Spongiform Encephalopathies (TSE Agents or Prions)
David M. Asher, PhDTransmissible Spongiform Encephalopathy Infectivity in Blood and Other Biologicals: Strategies for Detection, Decontamination and Removal
Luisa Gregori, PhDPathogenesis of Transmissible Spongiform Encephalopathies
Pedro Piccardo, MD
-
Contact FDA
(800) 835-4709
(301) 827-1800
Consumer Affairs Branch (CBER)
Division of Communication and Consumer Affairs
Office of Communication, Outreach and Development
Food and Drug Administration
1401 Rockville Pike
Suite 200N/HFM-47
Rockville, MD 20852-1448
-
-